Paper564384
Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast.
Sakai F and 6 others. J Endocrinol, 1978. Cited by 117 papers, by iCite.
Cite this record
ConductScience Library. Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast. Papers, record 564384. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/564384
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Sex Hormone-Binding Globulin | Major topic |
| Tamoxifen | Major topic |
| Transcortin | Major topic |
| Adult | |
| Aged | |
| Aging | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36205798 | Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology. | Cell Mol Life Sci | 2022 | https://conductscience.org/library/papers/36205798 | PubMed |
| 32565962 | Serum concentration of sex hormone-binding globulin in healthy volunteers and patients with breast cancer stratified by sex and age. | Oncol Lett | 2020 | https://conductscience.org/library/papers/32565962 | PubMed |
| 22890008 | Regulation of cortisol bioavailability--effects on hormone measurement and action. | Nat Rev Endocrinol | 2012 | https://conductscience.org/library/papers/22890008 | PubMed |
| 8883969 | Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer. | Breast Cancer Res Treat | 1996 | https://conductscience.org/library/papers/8883969 | PubMed |
| 8688341 | Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8688341 | PubMed |
| 7981451 | Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats. | Breast Cancer Res Treat | 1994 | https://conductscience.org/library/papers/7981451 | PubMed |
| 6684948 | Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6684948 | PubMed |
| 6540595 | Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6540595 | PubMed |
| 6423014 | Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications. | Breast Cancer Res Treat | 1983 | https://conductscience.org/library/papers/6423014 | PubMed |
| 6184101 | Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance. | Breast Cancer Res Treat | 1982 | https://conductscience.org/library/papers/6184101 | PubMed |
| 2952154 | The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients. | Br J Cancer | 1987 | https://conductscience.org/library/papers/2952154 | PubMed |
| 2765377 | Bone mineral content of women receiving tamoxifen for mastalgia. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2765377 | PubMed |
| 2690969 | Chemoprevention of breast cancer. | Breast Cancer Res Treat | 1989 | https://conductscience.org/library/papers/2690969 | PubMed |
| 2679843 | A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2679843 | PubMed |
| 2328214 | Phase I/II study of the anti-oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer Research Campaign Phase I/II Clinical Trials Committee study. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2328214 | PubMed |
| 1911227 | Influence of the antioestrogen tamoxifen on normal breast tissue. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1911227 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SERPINA6 | 866 | PubTator's text mining | https://conductscience.org/library/genes/866 | NCBI Gene |
| SHBG | 6462 | PubTator's text mining | https://conductscience.org/library/genes/6462 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/564384
GET https://conductscience.org/api/papers/v1/564384/authors